Joel Greenblatt - Gotham Asset Management
Holding/activity history for Atea Pharmaceuticals Inc (AVIR)
← All AVIR superinvestors
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2022 Q4 | 0 | 0.00 | Sell 100.00% | <0.01 | $4.18–6.32 · VW $5.08i | SEC | |
| 2022 Q3 | 11,431 | <0.01 | Reduce 48.17% | <0.01 | $5.41–9.79 · VW $7.48i | $65,000 | SEC |
| 2022 Q2 | 22,053 | <0.01 | Reduce 29.44% | <0.01 | $5.31–8.30 · VW $6.99i | $157,000 | SEC |
| 2022 Q1 | 31,254 | <0.01 | Add 7.09% | <0.01 | $5.38–9.35 · VW $6.77i | $226,000 | SEC |
| 2021 Q4 | 29,184 | <0.01 | Reduce 33.82% | 0.02 | $7.37–46.91 · VW $18.99i | $261,000 | SEC |
| 2021 Q3 | 44,095 | 0.06 | Add 97.16% | 0.03 | $21.10–46.62 · VW $30.93i | $1,546,000 | SEC |
| 2021 Q2 | 22,365 | 0.02 | Buy | 0.02 | $18.72–62.01 · VW $25.85i | $480,000 | SEC |